Saturday 17 October 2026 Export OPCH’s income statement to Excel — free account

Option Care Health, Inc.

In the quarter to June 2026, revenue grew 1.86%, EPS grew 12.9%, free cash flow grew 112.4% and total debt rose 4.38%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

31.20 0.02 −0.06%

Follow OPCH

Alert me

Market cap: $4.7B
P/E: 23.5×
Fwd P/E: 14.1×
Dividend yield: —
F-score: 5/9
Altman Z: 3.92
Beneish M: −2.38
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 2.86

Total sells 1.17

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	—	—	—	—	—	4	—	—	—	—	—
Sell	—	—	—	2	—	—	—	—	—	—	—	—

Insider Ownership 3.78%

Capital & Financial Ratios $m

Market Cap 4,680.00

Revenue 5,693.52

Net Income 209.58

Free Cash Flow 303.85

Net Debt 965.05

Current Ratio 1.47

Debt/Equity 0.92

P/E ratio 23.46

Fwd P/E 14.10

P/S ratio 0.84

P/B ratio 3.79

Past 5Y EPS Growth —

This Y EPS Growth 9.38%

Next Y EPS Growth 10.71%

Next Y revenue growth 1.90%

Next 5Y EPS Growth 10.52%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 35.15%

10-year low 10-year high

P/S against its own 10 years 42.17%

10-year low 10-year high

P/B against its own 10 years 58.51%

10-year low 10-year high

EV/Sales against its own 10 years 37.34%

10-year low 10-year high

EV/FCF against its own 10 years 14.24%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	344	413	233	194
Receivables	378	410	474	512
Inventory	274	388	471	400
Other	—	—	—	—
	1,094	1,323	1,265	1,201

	2023	2024	2025	Q'26
Payables	427	611	640	640
ST’ Debt	6	7	7	7
Other	—	—	—	—
	618	780	829	819

Compound Annual Growth %

	10y	5y	3y
Sales	19.12%	13.25%	12.72%
Cash Flow	0.00%	15.20%	(1.15%)
Earnings	0.00%	0.00%	11.30%
Book Value	0.00%	5.48%	(1.46%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	1,351	1,442	—	—	—
’25	1,333	1,416	1,435	1,465	5,650
’24	1,146	1,227	1,279	1,346	4,998
’23	1,016	1,069	1,093	1,124	4,302
’22	916	981	1,021	1,027	3,945
’21	759	860	892	927	3,439
’20	705	741	782	805	3,033

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(12)	184	—	—	—
’25	(7)	90	139	36	258
’24	(69)	196	160	36	323
’23	90	170	61	51	371
’22	33	104	87	43	268
’21	18	74	51	65	209
’20	18	35	48	26	127

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(21)	173	—	—	—
’25	(17)	81	130	22	217
’24	(75)	186	151	26	288
’23	84	162	53	35	333
’22	27	100	80	40	247
’21	15	70	46	51	183
’20	13	31	45	12	101

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.29	0.35	—	—	—
’25	0.28	0.31	0.32	0.37	1.27
’24	0.26	0.30	0.31	0.35	1.23
’23	0.21	0.63	0.31	0.32	1.48
’22	0.17	0.19	0.21	0.26	0.83
’21	(0.02)	0.18	0.20	0.41	0.77
’20	(0.11)	(0.04)	0.01	0.10	(0.04)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	3.92	4.28	9.24	6.24	5.74	15.37	21.32	24.23	21.39	22.62	Analyst estimates 2026–2028 Powerpack
	High	13.72	13.56	16.56	16.24	18.21	28.86	35.87	35.74	34.63	35.53
People
People	Employees	2,540	2,154	2,043	5,903	5,852	7,238	8,058	7,802	8,088	8,266
	Revenue/emp, $m	0.37	0.85	0.95	0.39	0.52	0.48	0.49	0.55	0.62	0.68
Income, $m
Income, $m	Revenue	936	1,828	1,940	2,310	3,033	3,439	3,945	4,302	4,998	5,650
	Gross margin, %	28.01	24.40	21.77	22.20	22.50	22.67	21.98	22.81	20.27	19.26
	EBT	(34)	(15)	(9)	(78)	(5)	116	206	359	284	283
	EBT margin, %	(3.65)	(0.80)	(0.45)	(3.38)	(0.17)	3.39	5.22	8.34	5.67	5.01
	Net income	(43)	4	(6)	(76)	(8)	140	151	267	212	208
	Depreciation	26	41	44	62	83	74	70	67	68	75
Per share, $
Per share, $	Revenue	39.92	12.82	13.60	14.78	16.76	19.12	21.78	24.04	29.13	34.85
	Earnings	(2.16)	0.03	(0.04)	(0.49)	(0.04)	0.78	0.83	1.49	1.23	1.28
	Cash flow	(1.82)	0.27	0.17	0.25	0.70	1.16	1.48	2.07	1.88	1.59
	Capex	(0.24)	(0.17)	(0.18)	(0.18)	(0.15)	(0.14)	(0.11)	(0.21)	(0.21)	(0.25)
	Free cash flow	(2.06)	0.09	(0.01)	0.07	0.56	1.02	1.36	1.86	1.68	1.34
	Book value	1.64	(0.59)	4.23	5.80	5.61	6.54	7.65	7.94	8.18	8.18
	Shares, m	23	143	143	156	181	180	181	179	172	162
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	36.27	35.54	23.03	18.56	24.89
	P/S	0.14	0.95	1.05	1.01	0.93	1.49	1.35	1.43	0.80	0.91
	P/B	0.00	0.00	3.38	2.57	2.79	4.35	3.85	4.32	2.83	3.89
	EV/Sales	0.61	1.19	1.31	1.54	1.27	1.76	1.55	1.59	0.94	1.08
	EV/FCF	(11.87)	162.83	(1,374.19)	(913.83)	38.36	33.13	24.76	20.59	16.26	28.06
Cash, $m
Cash, $m	Operating cash flow	(43)	38	24	39	127	209	268	371	323	258
	Capex	(6)	(24)	(26)	(28)	(27)	(26)	(21)	(38)	(36)	(41)
	Free cash flow	(48)	13	(2)	11	101	183	247	333	288	217
Balance, $m
Balance, $m	Working capital	43	81	227	229	223	251	429	476	542	436
	Total debt	452	481	539	1,286	1,124	1,066	1,064	1,063	1,111	1,161
	Net debt	442	436	503	1,219	1,025	946	770	719	699	928
	Shareholders’ equity	38	(85)	603	907	1,016	1,176	1,386	1,422	1,404	1,326
Returns, %
Returns, %	ROA	(9.13)	0.64	(0.60)	(3.78)	(0.31)	5.14	5.10	8.44	6.38	6.04
	ROIC	(1.43)	4.85	2.16	(0.01)	3.39	5.62	6.96	9.19	9.57	9.37
	ROE	90.57	(6.55)	(2.36)	(10.06)	(0.84)	12.77	11.75	19.03	14.99	15.20

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
PACS PACS Group, Inc.	$7.6B	27.6×	16.8×	+9.07% (above 0%: growing)	+45.45% (above 0%: growing)	+220.51% (above 0%: growing)	17.07%	7.66%	Compare
CHE Chemed Corporation	$6.7B	25.7×	20.4×	+8.80% (above 0%: growing)	+42.78% (above 0%: growing)	−43.51% (below 0%: shrinking)	32.90%	13.25%	Compare
CON Concentra Group Holdings Parent, Inc.	$5.0B	24.9×	17.0×	+10.03% (above 0%: growing)	+45.71% (above 0%: growing)	+91.62% (above 0%: growing)	31.70%	18.99%	Compare
LFST LifeStance Health Group, Inc.	$4.7B	88.3×	58.5×	+26.08% (above 0%: growing)	n/m	+55.22% (above 0%: growing)	35.15%	7.04%	Compare
OPCH Option Care Health, Inc.	$4.7B	23.5×	14.1×	+1.86% (above 0%: growing)	+12.90% (above 0%: growing)	+112.36% (above 0%: growing)	18.53%	5.90%
NHC National HealthCare Corporation	$3.9B	26.9×	8.4×	+8.83% (above 0%: growing)	+68.63% (above 0%: growing)	−41.57% (below 0%: shrinking)	100.00%	11.99%	Compare
ACHC Acadia Healthcare Company, Inc.	$2.9B	— (loss-making)	21.1×	−0.39% (below 0%: shrinking)	−63.64% (below 0%: shrinking)	+856.54% (above 0%: growing)	100.00%	10.14%	Compare
AVAH Aveanna Healthcare Holdings Inc.	$2.8B	9.5×	10.4×	+13.73% (above 0%: growing)	+46.15% (above 0%: growing)	+57.89% (above 0%: growing)	32.59%	11.93%	Compare
GRDN Guardian Pharmacy Services, Inc.	$2.5B	37.5×	39.5×	+2.16% (above 0%: growing)	+133.33% (above 0%: growing)	+60.83% (above 0%: growing)	22.75%	5.87%	Compare
Median of peers	$4.3B	26.9×	18.7×	+8.95%	+45.71%	+59.36%	32.75%	11.04%

All 55 Medical Care Facilities stocks →

Option Care Health, Inc. (OPCH) key facts

Option Care Health, Inc. (OPCH) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, OPCH traded at $31.20, a market capitalization of $4.7 billion.
Return on equity was 15.2% and debt-to-equity 0.92.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 3.92 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.